Serum total antioxidant status is higher in postmenopausal women and after estrogen replacement therapy [3]

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 8, 2002, Pages 850-852

  Bertrand, Philippe ^a   Starck, Marjorie ^a   Herbeth, Bernard ^a   Vincent Viry, Monique ^a   Schiele, Françoise ^a   Siest, Gérard ^a  

^a Centre de Medecine Preventive   (France)

Author keywords

Antioxidant status; Estrogen; Hormone replacement therapy; Menopause

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ANTIOXIDANT; COPPER; ESTROGEN; IRON; NANDROLONE; PROGESTERONE; TRANSFERRIN; URIC ACID; ZINC; GLUTATHIONE; LOW DENSITY LIPOPROTEIN;

ADULT; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ANTIOXIDANT ACTIVITY; ASSAY; BODY MASS; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG USE; ESTROGEN THERAPY; FEMALE; FRANCE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LETTER; MULTIPLE REGRESSION; NORMAL HUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; BLOOD; MIDDLE AGED;

ANTIOXIDANTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GLUTATHIONE; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; POSTMENOPAUSE;

EID: 0036380576     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.149     Document Type: Letter

References (11)

1. Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000; 46:28-49.
2. de Aloysio D, Altieri P, Penacchioni P, Mauloni M, Bottiglioni F. Premenopause-dependent changes. Gynecol Obstet Invest 1996; 42:120-7.
3. Zhu X, Bonet B, Gillenwater H, Knopp RH. Opposing effects of estrogen and progestins on LDL oxidation and vascular wall cytotoxicity: implications for atherogenesis. Proc Soc Exp Biol Med 1999; 222:214-21.
4. Ozden S, Dildar K, Kadir YH, Gulizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 2001; 38:165-70.
5. Cao G, Prior RL. Postprandial increases in serum antioxidant capacity in older women. J Appl Physiol 2000; 89:877-83.
6. Mendoza-Nuñez VM, Sanchez-Rodriguez MA, Retana-Ugalde R, Vargas-Guadarrama LA, Altamirano-Lozano MA. Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly. Mech Ageing Dev 2001; 122:835-47.
7. Muldoon MF, Kritchevsky SB, Evans RW, Kagan VE. Serum total antioxidant activity in relative hypo- and hypercholesterolemia. Free Radic Res 1996; 25:239-45.
8. Schiele F, Vincent-Viry M, Fournier B, Starck M, Siest G. Biological effects of eleven combined oral contraceptives on serum triglycerides, γ-glutamyl transferase, alkaline phosphatase, bilirubin, and other biochemical variables. Clin Chem Lab Med 1998; 36:871-8.
9. Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C, et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 1998; 36:35-42.
10. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, et al. Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000; 152:475-88.
11. Herzberg M, Lusky A, Blonder J, Frenkel Y. The effect of oestrogen replacement therapy on zinc in serum and urine. Obstet Gynecol 1996; 87: 1035-40.